EV Insights: Voices from Exosomes Europe

Discover how Spencer Marsh, Chief Scientific Officer at The Tiny Cargo Company, is revolutionising drug delivery through milk-derived exosomes. In this exclusive interview, Spencer shares his journey from cardiac tissue research to developing shelf-stable, orally-administered therapeutics. Learn about the company's innovative approach to loading pharmaceuticals into milk exosomes, the challenges facing the EV industry, and why exosome therapies may soon replace traditional cell therapies. Don't miss Spencer's insights at Exosomes Europe 2025, where he'll discuss manufacturing innovations and the untapped potential of alternative exosome sources.

Explore how Professor Bernd Giebel, researcher at University Hospital Essen and co-founder of Exosla, is transforming therapeutics through extracellular vesicles. In this interview, Bernd reveals his journey from stem cell biology to exosome innovation, including a breakthrough Graft-versus-Host Disease treatment. He discusses strategies to overcome production heterogeneity through immortalisation and clonal expansion, emphasising that "quality matters" in advancing exosome therapeutics. Don't miss his insights at Exosomes Europe, where he'll connect with industry experts to accelerate the clinical translation of these game-changing therapies.